Trial intelligence / Profile preview

Simvastatin add-on treatment for Langerhans cell histiocytosis

2009-014912-36Phase 2Terminated

Sponsor
Karolinska Institutet
Start
Jul 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, open-label, single-arm trial of simvastatin in Langerhans cell histiocytosis (LCH), sponsored by Karolinska Institutet. Primary endpoints: Treatment outcome evaluation and Clinical and laboratory monitoring. Started Jul 2009; status: terminated.

02

Drugs

simvastatin
03

Conditions

Langerhans cell histiocytosis (LCH)

Beyond the preview

Go deeper on 2009-014912-36.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-014912-36.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call